SIDS Susceptibility Pathways (Mus musculus)

From WikiPathways

Revision as of 05:12, 20 October 2012 by Nsalomonis (Talk | contribs)
Jump to: navigation, search
416, 335021, 40, 54405533454513574345434531612203252484320, 31, 363343138, 538372889249461046998, 534499994699846462937Other NeuronalDecreased relative SIDS expressionHNHeartNucleusCell MembraneSarcoplasmic ReticulumSPhBradycardiaPutative TRsPutative TRsNucleusIncreased long-QT with SIDSIncreased relative SIDS expressionAssociated with Infection and SIDSOSerotonin SignalingPutative TRsG5477AG-proteinHOC825TOHcAMP4R/4RK+2K+OInfant (<1 year in age)CaHO22+O BrownAdiposePutative TRsPutative TRsNHPutative TRPutative TRNa+OHNerve TerminalHNPutative TRSPhVagal ToneSIDS associated polymorphismsPutative TRsSerotonin Synthesis and MetabolismGq signalingGs signalingTRrHOCardiac myocyteIncreased brainstem hypoplasia with SIDSOtherThermoregulationSPhSPhIVS-191_190insAPutative TRsPutative TRSPhPutative TRSleep2misc coding regioncircadianHNPutative TRMiscelaneous SIDS AssociatedG2989TSIDS Susceptibility Pathwaysrs2856966BrainNH Slowly-Activating Potassium CurrentNHTR: Transcriptional RegulationHNdepressionFatty Liver (Hepatic steatosis) and SIDSSoma MembraneSerotonin Neuron SpecificationSph: SIDS Phenotype Animal ModelSerotonin producing raphe neuronRapidly-activating Potassium CurrentPutative TR+101A>Grs6295 (-1019)TRrOHPutative TRsFocal AdhesionsGi signaling2235171730363642430181275851AcadmRestCC2D1AGATA2DdcYBX1Tph15-HTGata3ArKCNQ1C4BEN1FevTPH25-HTPHOX2BKcnh2RetPou3f2NR3C1Adcyap1Cav35-HTPPHOX2AEce1TLX35-HTCdca7lFoxm1HTR2AHTR1AEp300TnfVipr1CHRNB4PPARGC1BRYR2Slc6a4Sp1Ppargc1aASCL1Chrnb2NFYAIl10CtcfCav3Hspd1Creb1FevSCN5ANkx2-2Nfkb1Sp1DdcIL8Hes5C4AHTR1A5-HIAAHadhaAdcyap1RORARestChrna4NicotineSLC9A3Il6Vipr2HES1Adcyap1r1AvpL-TryptophanMaoaTPH2MaoaKcnh2KCNQ1RYR2SCN5ALMX1BPou3f2GNB3Deaf1RestIl6raTph1Nkx3-1Esr22633274519, 552310254714634492643395-HIAA4056385


Description

In this model, we provide an integrated view of Sudden Infant Death Syndrome (SIDS) at the level of implicated tissues, signaling networks and genetics. The purpose of this model is to serve as an overview of research in this field and recommend new candidates for more focused or genome wide analyses. SIDS is the sudden and unexpected death of an infant (less than 1 year of age), almost always during deep sleep, where no cause of death can be found by autopsy. Factors that mediate SIDS are likely to be both biological and behavioral, such as sleeping position, environment and stress during a critical phase of infant development (http://www.nichd.nih.gov/health/topics/Sudden_Infant_Death_Syndrome.cfm). While no clear diagnostic markers currently exist, several polymorphisms have been identified which are significantly over-represented in distinct SIDS ethnic population. The large majority of these polymorphisms exist in genes associated with neuronal signaling, cardiac contraction and inflammatory response. These and other lines of evidence suggest that SIDS has a strong autonomic nervous system component (PMID:12350301, PMID: 20124538). One of the neuronal nuclei most strongly implicated in SIDS has been the raphe nucleus of the brain stem. In this nuclei there are ultrastructural, cellular and molecular changes associated with SIDS relative to controls (PMID:19342987, PMID: 20124538). This region of the brain is responsible for the large majority of neuronal serotonin produced and is functionally important in the regulation of normal cardiopulmonary activity, sleep and thermoregulation (see associated references).

Genes associated with serotonin synthesis and receptivity have some of the strongest genetic association with SIDS. Principle among these genes the serotonin biosynthetic enzyme TPH2, the serotonin transporter SLC6A4 and the serotonin receptor HTR1A. SLC6A4 exhibits decreased expression in the raphe nucleus of the medulla oblongata and polymorphisms specifically associated with SIDS (PMID:19342987). In 75% of infants with SIDS, there is decreased HTR1A expression relative to controls along with an increase in the number of raphe serotonin neurons (PMID:19342987). Over-expression of the mouse orthologue of the HTR1A gene in the juvenile mouse medulla produces an analogous phenotype to SIDS with death due to bradycardia and hypothermia (PMID:18599790). These genes as well as those involved in serotonin synthesis are predicted to be transcriptionally regulated by a common factor, FEV (human orthologue of PET-1). PET-1 knock-out results in up to a 90% loss of serotonin neurons (PMID:12546819), while polymorphisms in FEV are over-represented in African American infants with SIDS. In addition to FEV, other transcription factors implicated in the regulation of these genes (Putative transcriptional regulators (TRs)) and FEV are also listed (see associated references). In addition to serotonin, vasopressin signaling and its regulation by serotonin appear to be important in a common pathway of cardiopulmonary regulation (PMID:2058745). A protein that associates with vasopressin signaling, named pituitary adenylate cyclase-activating polypeptide (ADCYAP1), results in a SIDS like phenotype, characterized by a high increase in spontaneous neonatal death, exacerbated by hypothermia and hypoxia (PMID:14608012), when disrupted in mice. Protein for this gene is widely distributed throughout the central nervous system (CNS), including autonomic control centers (PMID:12389210). ADCYAP1 and HTR1A are both predicted to be transcriptionally regulated by REST promoter binding. Regulation of G-protein coupled signaling pathways is illustrated for these genes, however, it is not clear whether ADCYAP1 acts directly upon raphe serotonin neurons.

Another potentially important class of receptors in SIDS is nicotine. Receptors for nicotine are expressed in serotonin neurons of the raphe throughout development (PMID:18986852). Application of nicotine or cigarette smoke is sufficient to inhibit electrical activity of raphe serotonin neurons (PMID:17515803) and chronic nicotine infusion in rats decreases expression of SLC6A4 (PMID:18778441). Furthermore, nicotine exposure reduces both HTR1A and HTR2A immunoreactivity in several nuclei of the brainstem (PMID:17451658).

In addition to CNS abnormalities, several studies have identified a critical link between cardiac arrhythmia (long QT syndrome) and SIDS (PMID:18928334). A number of genetic association studies identified functionally modifying mutations in critical cardiac channels in as many as 10% of all SIDS cases (PMID:18928334). These mutations have been predicted to predispose infants for long QT syndrome and sudden death. The highest proportion of SIDS associated mutations (both inherited and sporadic) is found in the sodium channel gene SCN5A. Examination of putative transcriptional regulators for these genes, highlights a diverse set of factors as well as a relatively common one (SP1).

Finally, several miscellaneous mutations have been identified in genes associated with inflammatory response and thermoregulation. Infection is considered a significant risk factor for SIDS (PMID:19114412). For inflammatory associated genes, such as TNF alpha, interleukin 10 and complement component 4, many of these mutations are only significant in the presence of infection and SIDS. In addition to these mutations, cerebrospinal fluid levels of IL6 are increased in SIDS cases as well as IL6R levels in the arcuate nucleus of the brain, another major site of serotonin synthesis (PMID:19396608). Genes such as ILR6 and ADCYAP1 are also associated with autoimmune disorders, thus SIDS may also be associated with autoinflammation of autonomic centers in the brain. Regulation of thermogenesis by brown adipose tissue has been proposed be an important component of SIDS, given that SIDS incidence is highest in the winter time and that animal models of SIDS demonstrate variation in body temperature. Interestingly, activation of raphe HTR1A decreases both shivering and peripheral vasoconstriction in piglets (18094064). Although a putative significant polymorphism was identified in the thermoregulator gene HSP60, this only occurred in one SIDS case. It is important to note that in the large majority of all these studies, sleeping position and smoking were among the most significant risk factors for SIDS.

In loving memory of Milo Salomonis (http://www.milosalomonis.org).

Comments

HomologyConvert 
This pathway was inferred from Homo sapiens pathway WP706(r45233) with a 62% conversion rate.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography


History

View all...
CompareRevisionActionTimeUserComment
65313view17:42, 6 June 2013MaintBotDeleted pathway: author requested delete
52939view20:39, 24 October 2012NsalomonisReverted to version '21:21, 1 December 2011' by Nsalomonis
52731view05:15, 20 October 2012NsalomonisSpecify description
52730view05:13, 20 October 2012NsalomonisReverted to version '21:21, 1 December 2011' by Nsalomonis
52729view05:12, 20 October 2012NsalomonisReverted to version '05:07, 20 October 2012' by Nsalomonis
52728view05:11, 20 October 2012NsalomonisSpecify description
52727view05:07, 20 October 2012NsalomonisSpecify description
45988view21:21, 1 December 2011MaintBotNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
5-HIAAMetaboliteHMDB00763 (HMDB)
5-HTMetaboliteHMDB00259 (HMDB)
5-HTPMetaboliteHMDB00472 (HMDB)
ASCL1GeneProduct
AcadmGeneProduct11364 (Entrez Gene)
Adcyap1GeneProduct11516 (Entrez Gene)
Adcyap1r1GeneProduct11517 (Entrez Gene)
ArGeneProduct11835 (Entrez Gene)
AvpGeneProduct11998 (Entrez Gene)
C4AGeneProduct
C4BGeneProduct
CC2D1AGeneProduct
CHRNB4GeneProduct
Cav3GeneProduct12391 (Entrez Gene)
Cdca7lGeneProduct217946 (Entrez Gene)
Chrna4GeneProduct11438 (Entrez Gene)
Chrnb2GeneProduct11444 (Entrez Gene)
Creb1GeneProduct12912 (Entrez Gene)
CtcfGeneProduct13018 (Entrez Gene)
DdcGeneProduct13195 (Entrez Gene)
Deaf1GeneProduct54006 (Entrez Gene)
EN1GeneProduct
Ece1GeneProduct230857 (Entrez Gene)
Ep300GeneProduct328572 (Entrez Gene)
Esr2GeneProduct13983 (Entrez Gene)
FevGeneProduct260298 (Entrez Gene)
Foxm1GeneProduct14235 (Entrez Gene)
GATA2GeneProduct
GNB3GeneProduct
Gata3GeneProduct14462 (Entrez Gene)
HES1GeneProduct
HTR1AGeneProduct
HTR2AGeneProduct
HadhaGeneProduct97212 (Entrez Gene)
Hes5GeneProduct15208 (Entrez Gene)
Hspd1GeneProduct15510 (Entrez Gene)
IL8GeneProduct
Il10GeneProduct16153 (Entrez Gene)
Il6GeneProduct16193 (Entrez Gene)
Il6raGeneProduct16194 (Entrez Gene)
KCNQ1GeneProduct
Kcnh2GeneProduct16511 (Entrez Gene)
L-TryptophanMetaboliteHMDB00929 (HMDB)
LMX1BGeneProduct
MaoaGeneProduct17161 (Entrez Gene)
NFYAGeneProduct
NR3C1GeneProduct
Nfkb1GeneProduct18033 (Entrez Gene)
NicotineMetaboliteHMDB01934 (HMDB)
Nkx2-2GeneProduct18088 (Entrez Gene)
Nkx3-1GeneProduct18095 (Entrez Gene)
PHOX2AGeneProduct
PHOX2BGeneProduct
PPARGC1BGeneProduct
Pou3f2GeneProduct18992 (Entrez Gene)
Ppargc1aGeneProduct19017 (Entrez Gene)
RORAGeneProduct
RYR2GeneProduct
RestGeneProduct19712 (Entrez Gene)
RetGeneProduct19713 (Entrez Gene)
SCN5AGeneProduct
SLC9A3GeneProduct
Slc6a4GeneProduct15567 (Entrez Gene) Contains an alternative promoter in the first and possibly second intron.
Sp1GeneProduct20683 (Entrez Gene)
TLX3GeneProduct
TPH2GeneProduct
TnfGeneProduct21926 (Entrez Gene)
Tph1GeneProduct21990 (Entrez Gene)
Vipr1GeneProduct22354 (Entrez Gene)
Vipr2GeneProduct22355 (Entrez Gene)
YBX1GeneProduct

Annotated Interactions

No annotated interactions